KHATEREH ASSADI: Open Payments
NPI 1427327766 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 6 payments from 4 companies in 2025. Trend: 2023 $426 · 2024 $21 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $250 |
| Lilly USA, LLC | 1 | $125 |
| Dexcom, Inc. | 2 | $86 |
| ViiV Healthcare Company | 1 | $32 |
Products named: Ozempic, Wegovy, MOUNJARO, Dexcom G6 Transmitter, APRETUDE.
Industry payments across CA — which companies pay providers there.
